FMC Corporation announced regulatory approval for Tremisia fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland. This advances the commercialization of FMC's fluindapyr fungicide technology.
Ukraine is a strategically important agricultural market, ranking among the world's largest exporters of sunflower, oilseed rape, and wheat. Tremisia fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, delivering a dual mode of action to maintain healthy crops for an extended period. It targets a broad spectrum of economically significant diseases, including Alternaria, Sclerotinia, Septoria, and rust.
This registration fills an important gap in disease management options for Ukrainian growers, providing a high-performance tool to protect crops from devastating diseases. The Ukraine registration builds on FMC's successful commercialization of fluindapyr-based products in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with further launches anticipated in Bolivia, Chile, Colombia, Honduras, and India.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.